|
US6890909B1
(en)
*
|
1997-07-04 |
2005-05-10 |
Fujisawa Pharmaceutical Co., Ltd. |
Brain-protective agent
|
|
US6133308A
(en)
*
|
1997-08-15 |
2000-10-17 |
Millennium Pharmaceuticals, Inc. |
Synthesis of clasto-lactacystin beta-lactone and analogs thereof
|
|
US20090042807A1
(en)
*
|
1998-05-20 |
2009-02-12 |
Nisar Ahmed Khan |
Oligopeptide treatment of ischemia reperfusion injury
|
|
US6844315B2
(en)
|
1998-05-20 |
2005-01-18 |
Erasmus Universiteit Rotterdam |
Immunoregulator
|
|
US6921751B1
(en)
|
1998-05-20 |
2005-07-26 |
Erasmus Universiteit Rotterdam |
Immunoregulator
|
|
US7175679B2
(en)
|
2001-03-29 |
2007-02-13 |
Biotempt B.V. |
Oligopeptide treatment of NF-κB mediated inflammation
|
|
EP1138692A1
(en)
|
2000-03-29 |
2001-10-04 |
Erasmus Universiteit Rotterdam |
Fragments of human chorionic gonadotropin (hcg) as immunoregulator
|
|
US8680059B2
(en)
*
|
1998-05-20 |
2014-03-25 |
Biotempt B.V. |
Oligopeptide acetate and formulations thereof
|
|
US20030220258A1
(en)
*
|
2001-12-21 |
2003-11-27 |
Robbert Benner |
Treatment of ischemic events
|
|
EP1223948A2
(en)
*
|
1999-09-13 |
2002-07-24 |
CHARLOTTE-MECKLENBURG HOSPITAL doing business as Carolinas Medical Center |
Method of inhibiting nf-kappa-b with heparin, for treating cardiovascular diseases and inflammations
|
|
US7358330B2
(en)
|
2001-03-29 |
2008-04-15 |
Biotempt B.V. |
Immunoregulatory compositions
|
|
US7576174B2
(en)
|
2000-03-29 |
2009-08-18 |
Biotempt B.V. |
Compositions capable of reducing elevated blood urea concentration
|
|
EP1300418A1
(en)
|
2001-10-04 |
2003-04-09 |
Erasmus Universiteit Rotterdam |
Gene regulation by oligopeptides
|
|
USRE43279E1
(en)
|
2000-03-29 |
2012-03-27 |
Biotemp B.V. |
Compositions capable of reducing elevated blood urea concentration
|
|
US6713459B1
(en)
*
|
2000-04-28 |
2004-03-30 |
East Tennessee State University |
Methods for the prophylactic and therapeutic treatment of cardiac tissue damage
|
|
JP4395549B2
(ja)
*
|
2000-11-16 |
2010-01-13 |
ザ レジェンツ オブ ザ ユニヴァースティ オブ カリフォルニア |
薬物及び発酵生成物の発見のための海洋放線菌分類群
|
|
ES2571219T3
(es)
|
2001-01-25 |
2024-09-23 |
The United States Of America Represented By The Sec Dep Of Health And Human Services |
Formulación de compuestos de ácido borónico
|
|
BR0209883A
(pt)
|
2001-05-21 |
2004-06-08 |
Alcon Inc |
Uso de inibidores da proteasoma para o tratamento de distúrbios do olho seco
|
|
US7112588B2
(en)
|
2001-05-21 |
2006-09-26 |
Alcon, Inc. |
Use of proteasome inhibitors to treat dry eye disorders
|
|
NZ532310A
(en)
*
|
2001-10-05 |
2007-02-23 |
Combinatorx Inc |
Combinations comprising a tetra-substituted pyrimidopyrimidine and a corticosteroid for the treatment of immunoinflammatory disorders
|
|
CA2466928A1
(en)
*
|
2001-12-10 |
2003-07-03 |
Yansheng Du |
Treatment of neurodegenerative and cardiovascular disorders
|
|
US20080318871A1
(en)
*
|
2001-12-21 |
2008-12-25 |
Khan Nisar A |
Treatment of neurological disorders
|
|
US20080242837A1
(en)
*
|
2001-12-21 |
2008-10-02 |
Khan Nisar A |
Peptide compositions
|
|
US7560433B2
(en)
|
2001-12-21 |
2009-07-14 |
Biotempt B.V. |
Treatment of multiple sclerosis (MS)
|
|
US7786084B2
(en)
*
|
2001-12-21 |
2010-08-31 |
Biotempt B.V. |
Treatment of burns
|
|
US7501391B2
(en)
|
2001-12-21 |
2009-03-10 |
Biotempt B.V. |
Treatment of transplant survival
|
|
US7176232B2
(en)
|
2002-06-24 |
2007-02-13 |
The Regents Of The University Of California |
Salinosporamides and methods for use thereof
|
|
US7517529B2
(en)
*
|
2003-04-08 |
2009-04-14 |
Biotempt B.V. |
Treatment of type I diabetes
|
|
US20050004164A1
(en)
*
|
2003-04-30 |
2005-01-06 |
Caggiano Thomas J. |
2-Cyanopropanoic acid amide and ester derivatives and methods of their use
|
|
KR20060026052A
(ko)
*
|
2003-06-20 |
2006-03-22 |
니리어스 파마슈티컬즈, 인코퍼레이션 |
암, 염증 및 감염성 질환의 치료를 위한 [3.2.0]헤테로사이클릭 화합물 및 그 유사체의 사용방법
|
|
EP2441767B1
(en)
*
|
2003-06-20 |
2015-06-10 |
The Regents of The University of California |
Salinosporamides and methods for use thereof
|
|
WO2005023187A2
(en)
|
2003-08-28 |
2005-03-17 |
Kem David C |
Inhibitor of cardiac tachyarrhythmias
|
|
US20090227505A1
(en)
*
|
2004-01-07 |
2009-09-10 |
Biotempt B.V. |
Methods and uses for protein breakdown products
|
|
SE0400399D0
(sv)
*
|
2004-02-20 |
2004-02-20 |
Index Pharmaceuticals Ab |
Methods and compositions for the treatment or prevention of secondary ischemic injury
|
|
US7579371B2
(en)
|
2004-04-30 |
2009-08-25 |
Nereus Pharmaceuticals, Inc. |
Methods of using [3.2.0] heterocyclic compounds and analogs thereof
|
|
BRPI0509824A
(pt)
|
2004-04-30 |
2007-10-09 |
Nereus Pharmaceuticals Inc |
compostos heterocìclicos [3.2.0] e métodos de uso dos mesmos
|
|
US7425580B2
(en)
*
|
2004-05-19 |
2008-09-16 |
Wyeth |
(Diaryl-methyl)-malononitriles and their use as estrogen receptor ligands
|
|
US20060008454A1
(en)
*
|
2004-07-07 |
2006-01-12 |
Dr. Helmut Brunar |
Use of a compound for enhancing the expression of membrane proteins on the cell surface
|
|
WO2006002453A2
(en)
*
|
2004-07-07 |
2006-01-12 |
Biodevelops Pharma Entwicklung Gmbh |
Use of a deubiquitinating compound for enhancing the expression of membrane proteins on the cell surface
|
|
EP1785431B1
(en)
*
|
2004-08-30 |
2016-01-20 |
Toray Industries, Inc. |
Fractionation apparatus
|
|
WO2006062732A2
(en)
*
|
2004-11-19 |
2006-06-15 |
Synta Pharmaceuticals Corp. |
Compounds acting at the centrosome
|
|
SG157365A1
(en)
*
|
2004-12-03 |
2009-12-29 |
Dana Farber Cancer Inst Inc |
Compositions and methods for treating neoplastic diseases
|
|
JP4846799B2
(ja)
*
|
2005-07-05 |
2011-12-28 |
バイオテンプト ベー．フェー． |
腫瘍の治療
|
|
WO2007002972A2
(en)
*
|
2005-07-06 |
2007-01-11 |
Biodevelops Pharma Entwicklung Gmbh |
Use of a compound for enhancing the expression of membrane proteins on the cell surface
|
|
WO2007011757A1
(en)
*
|
2005-07-14 |
2007-01-25 |
Myogen, Inc. |
Use of inhibitors of the ubiquitin proteasome pathway for increasing contractility of the heart
|
|
US7691896B2
(en)
*
|
2005-08-10 |
2010-04-06 |
President And Fellows Of Harvard College |
Analogs of salinosporamide A
|
|
EP1864692A1
(en)
*
|
2006-06-07 |
2007-12-12 |
Biotempt B.V. |
Use of peptides for the control of radiation injury
|
|
ES2293834B1
(es)
*
|
2006-07-20 |
2009-02-16 |
Consejo Superior Investig. Cientificas |
Compuesto con actividad inhibidora de las interacciones ubc13-uev, composiciones farmaceuticas que lo comprenden y sus aplicaciones terapeuticas.
|
|
WO2008095195A2
(en)
*
|
2007-02-02 |
2008-08-07 |
Nereus Pharmaceuticals, Inc. |
Lyophilized formulations of salinosporamide a
|
|
DK2120991T3
(da)
*
|
2007-02-12 |
2014-04-28 |
Biotempt Bv |
Behandling af traumatisk blødning med korte oligopeptider
|
|
WO2008137780A2
(en)
*
|
2007-05-04 |
2008-11-13 |
Nereus Pharmaceuticals, Inc. |
Use of [3.2.0] heterocyclic compounds and analogs thereof for treating infectious diseases
|
|
US7442830B1
(en)
|
2007-08-06 |
2008-10-28 |
Millenium Pharmaceuticals, Inc. |
Proteasome inhibitors
|
|
US8394816B2
(en)
|
2007-12-07 |
2013-03-12 |
Irene Ghobrial |
Methods of using [3.2.0] heterocyclic compounds and analogs thereof in treating Waldenstrom's Macroglobulinemia
|
|
CN102089312A
(zh)
*
|
2008-05-12 |
2011-06-08 |
尼瑞斯药品公司 |
作为蛋白酶体抑制剂的Salinosporamide衍生物
|
|
EP2730579A1
(en)
|
2008-06-17 |
2014-05-14 |
Millennium Pharmaceuticals, Inc. |
Boronate ester compounds and pharmaceutical compositions thereof
|
|
AR075090A1
(es)
|
2008-09-29 |
2011-03-09 |
Millennium Pharm Inc |
Derivados de acido 1-amino-2-ciclobutiletilboronico inhibidores de proteosoma,utiles como agentes anticancerigenos, y composiciones farmaceuticas que los comprenden.
|
|
EP2305285A1
(en)
|
2009-09-29 |
2011-04-06 |
Julius-Maximilians-Universität Würzburg |
Means and methods for treating ischemic conditions
|
|
WO2011090159A1
(ja)
|
2010-01-22 |
2011-07-28 |
独立行政法人科学技術振興機構 |
蛋白質の分解活性を測定するためのプローブ試薬
|
|
MX2012011298A
(es)
|
2010-03-31 |
2012-11-06 |
Millennium Pharm Inc |
Derivados del acido 1-amino-2-ciclopropiletilboronico.
|
|
CN104411316B
(zh)
|
2012-05-09 |
2018-05-01 |
坎泰克斯制药股份有限公司 |
骨髓抑制的治疗
|
|
CA2909519A1
(en)
|
2013-04-16 |
2014-10-23 |
Cipla Limited |
Process for the preparation of bortezomib mannitol ester
|
|
CN111116622A
(zh)
|
2014-02-03 |
2020-05-08 |
俄亥俄州创新基金会 |
硼酸酯和其药物制剂
|
|
MA39964A
(fr)
|
2014-05-20 |
2015-11-26 |
Millennium Pharm Inc |
Inhibiteurs du protéasome contenant du bore destinés à être utilisés après une thérapie contre le cancer primaire
|
|
US10052346B2
(en)
|
2015-02-17 |
2018-08-21 |
Cantex Pharmaceuticals, Inc. |
Treatment of myelodysplastic syndromes with 2-O and,or 3-O desulfated heparinoids
|
|
EP3270891A1
(en)
|
2015-03-17 |
2018-01-24 |
Leon-Nanodrugs GmbH |
Nanoparticles comprising a stabilized boronic acid compound
|
|
EP3700567A4
(en)
*
|
2017-10-26 |
2021-09-29 |
The Regents of The University of California |
INHIBITION OF OXIDATION-SPECIFIC EPITOPIA TO TREAT REPERFUSION ISCHEMIC DAMAGE
|
|
KR20250173600A
(ko)
|
2023-03-17 |
2025-12-10 |
옥시토프 파마 비.브이. |
항-포스포콜린 항체 및 그 사용 방법
|